Clinical Trials Logo

Clinical Trial Summary

In this study, the effect of oxycodone combined with ultrasound-guided paravertebral nerve block on the postoperative analgesic effect of thoracoscopic lung cancer was investigated, and the effect and reasonable dose of oxycodone were explored, which provided a reference for the clinical multimodal analgesia after thoracoscopic lung cancer surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05742256
Study type Interventional
Source Qianfoshan Hospital
Contact Pengcai Shi, Chief physician
Phone 13791126828
Email shipc1997@163.com
Status Not yet recruiting
Phase Phase 1
Start date March 1, 2023
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03145272 - Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Thai Pediatric Surgical Patients Phase 4
Not yet recruiting NCT06444997 - Efficacy and Safety of Oxycodone Hydrochloride for Long-term Analgesia in ICU Patients Phase 4
Recruiting NCT05962294 - Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain
Recruiting NCT03016364 - Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain Phase 1/Phase 2
Recruiting NCT06276179 - Epidural Oxycodone for Pain Management for Lower Limb Amputation N/A
Not yet recruiting NCT05795478 - Effects of Oxycodone Combined With Pregabalin on Chronic Postsurgical Pain in Spinal Surgery N/A